Green Cross Holdings Corporation (KRX:005250)

Market Cap	751.40B +15.1%
Revenue (ttm)	2.40T +9.9%
Net Income	127.58B
EPS	2,832.40
Shares Out	45.40M
PE Ratio	5.84
Forward PE	n/a
Dividend	500.00 (2.97%)
Ex-Dividend Date	Mar 30, 2026

Volume	94,640
Average Volume	107,312
Open	16,800
Previous Close	16,810
Day's Range	16,520 - 16,800
52-Week Range	12,000 - 17,700
Beta	0.55
RSI	61.11
Earnings Date	Feb 10, 2026

About Green Cross Holdings

Green Cross Holdings Corporation operates as a biotechnology company. The company provides prescription drugs and over the counter drugs; aseptic fill and finish services for drug manufacturing; and pharmaceutical logistics services. It also researches and develops plasma derivatives for von Willebrand disease and primary immunodeficiency; vaccines for mRNA flu, anthrax, tetanus, diphtheria, pertussis, tuberculosis, and varicella; recombinant treatments for acquired thrombotic thrombocytopenic purpura, fabry, hemophilia, hunterase, colon cancer...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1967
• Employees: 144
• Stock Exchange: Korea Stock Exchange
• Ticker Symbol: 005250